Jul 21, 2019 | Financial Planning
With the Dow Jones Industrial Average over 27,000, the S&P 500 index moving past the 3,000 mark for the first time; the Nasdaq composite likewise shattering its previous record, closing above 8,200, the mood in Wall Street is almost giddy. But the reasons are...
Jun 22, 2019 | Financial Planning
Yields on 10-year Treasuries broke below 2% for the first time since 2016 this week after the Federal Reserve signaled it’s ready to lower borrowing costs, prompting a flurry of bets that a rate cut will happen in July. The U.S.-China trade dispute remains hot. On...
May 26, 2019 | Financial Planning
Earlier this week, the House passed the bill, which delays until 72, the age at which retirees must start withdrawing from 401ks and individual retirement accounts and removes the age limit at which taxpayers must stop contributing. Currently, taxpayers have to stop...
Mar 31, 2019 | Financial Planning
Earlier this week, the House Ways & Means Committee introduced a bill to raise the RMD (required minimum distributions) age to 72 from 70½. The Ways and Means Committee is expected to vote on the new measure next week. Investors who reach age 70½ are faced with a...
Mar 24, 2019 | Financial Planning
As the market searches for direction, one indicator is pointing toward a more somber scenario. The interest rate on the U.S. Treasury 10-year bond just fell below the rate on the 3-month bill in response to the Fed’s March announcement. The Treasury yield curve...
Jan 13, 2019 | Financial Planning
Earlier this week, Bluebird Bio announced it may have a found a way to handle the expected seven-figure cost of its experimental gene therapy: getting customers to pay on installment. The price of its therapy to rare inherited blood disease is expected to be ~$2...
